Related Experiment Video
Updated: Aug 3, 2026
A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms
Published on: October 21, 2010
Utilization and impact of a rapid Candida panel on antifungal stewardship program within a large community hospital
Taylor D Steuber1, Glady's Tucker-Heard2, Jonathan Edwards3
1Auburn University Harrison School of Pharmacy, Department of Pharmacy Practice, 301 Governors Drive SW, Huntsville, AL 35801; Huntsville Hospital, Department of Pharmacy, 101 Sivley Road, Huntsville, AL 35801.
Background:
The T2 Candida Panel (T2CP) bodes high sensitivity and specificity to detect candidemia, enabling providers to make quick therapy decisions and possibly decrease mortality. However, utilization in practice and clinical application remains to be evaluated.
Objectives:
To evaluate the overall provider-utilization of the T2CP at a large community hospital.
Methods:
This single center, retrospective, observational study compared antifungal management in all patients with positive or negative T2CP. Additional endpoints included patient-specific variables influencing antifungal management decisions.
Results:
Six hundred twenty-eight T2CP results were evaluated. Antifungal optimization occurred in 54% of patients who had antifungal orders at the time of T2CP test. Antifungal therapy was avoided in 60.4% of negative cases. Patients with negative T2CP had significantly fewer days of therapy compared to positive tests.
Conclusions:
Although the T2CP led to fewer days of antifungal therapy with negative tests, many opportunities for improvement in antifungal stewardship were identified, specifically, with negative tests.
